Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients

• Xiaolun Huang,

  Affiliation Department of Hepatobiliary-Pancreatic Surgery and Cell Transplant Center, the Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China

  ⨯
• Jeanna L. Knoble,

  Affiliation Department of Hematology and Oncology, Zangmeister Cancer Center, Mount Carmel Health System, Columbus, Ohio, United States of America

  ⨯
• Ming Zeng ,

  * E-mail: miller2002@yahoo.com

  Affiliation Department of Radiation Oncology, Mount Carmel Health System, Columbus, Ohio, United States of America

  ⨯
• Fernando N. Aguila,

  Affiliation Central Ohio Surgical Associates, Inc., Columbus, Ohio, United States of America

  ⨯
• Tara Patel,

  Affiliation Department of Hematology and Oncology, Zangmeister Cancer Center, Mount Carmel Health System, Columbus, Ohio, United States of America

  ⨯
• Lowell W. Chambers,

  Affiliation Central Ohio Surgical Associates, Inc., Columbus, Ohio, United States of America

  ⨯
• Honglin Hu,

  Affiliation Cancer Center, the Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China

  ⨯
• Hao Liu

  Affiliation Cancer Center, the Affiliated Hospital of University of Electronic Science and Technology, Chengdu, Sichuan, China

  ⨯